UK budget sees R&D tax credits rise
December 3, 2014Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences
Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …
Evotec and Sanofi enter pre-clinical deal
December 3, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse
Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …
Packaging machinery specialist, Sepha Ltd, Wins National Award for Excellence in Innovation
December 3, 2014The Northern Ireland-based packaging machinery manufacturer, Sepha Ltd. has won the award for Excellence in Innovation from the UK Chamber …
NICE recommends test to reduce antibiotic use
December 3, 2014Sales and Marketing Antibiotics, GPs, NICE, UK, doctors, icl, pneumonia
NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …
Novartis flu vaccine cleared following safety probe
December 3, 2014Sales and Marketing GSK, Novartis, Vaccine, flu, fluad
The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …
Hunt sets out plans for expanded NHS budget
December 3, 2014Sales and Marketing Budget, Hunt, NHS, UK, election, health, king's fund
Health secretary Jeremy Hunt has laid out his plans for the future of the NHS in a speech to parliament, …
Otsuka buys Avanir for $3.5 billion
December 3, 2014Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir
Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …
‘Postcode lottery’ still cause of many lung cancer deaths
December 3, 2014Research and Development, Sales and Marketing DoH, Roche, astranzeneca, lung cancer, nlca, oncology, pd-1
Patients are still pointlessly dying of lung cancer due to a ‘postcode lottery’ of services according to new results from …
EMA discussing executive director post
December 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Guido Rasi, andreas pott
The European Medicines Agency has confirmed that Andreas Pott will remain in charge of the body in place of the …
MHRA approves Google gene test for UK
December 2, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, FDA, MHRA, UK, US, gene, google, test
The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …
Roche buys Ariosa Diagnostics
December 2, 2014Research and Development, Sales and Marketing IPF, IQuum, InterMune, Roche, ariosa, cfdna, diabetes, genia, seragon
Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into …
FDA clears Sanofi TB drug indication
December 2, 2014Research and Development, Sales and Marketing Bedaquiline, FDA, Sanofi, WHO, priftin, rifapentine, sirturo
The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …
NICE U-turn on Roche leukaemia drug
December 2, 2014Sales and Marketing Gazyvaro, MabThera, NHS, NICE, Roche, leukaemia, obinutuzumab
NICE has reversed its decision on Roche’s chronic lymphocytic leukaemia (CLL) drug Gazyvaro only two months after rejecting the drug. …
NuCana appoints GSK oncology head
December 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana
Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors. Paoletti has been …
AZ and Lilly Alzheimer’s drug enters trials
December 1, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly
AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …
£2 billion government plan to ‘save the NHS’
December 1, 2014Sales and Marketing Conservatives, NHS, Osborne, UK, balls, election, spending
George Osborne in his Autumn Statement on Wednesday will announce an extra £2 billion funding for the NHS in an attempt …
CRF Health expands leadership team
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing crf health, enbuska, john blakeley
Clinical trials e-solutions firm CRF Health has announced two new additions to the company’s executive leadership team. John Blakeley (pictured) …
George Freeman: UK pharma is vital for our landscape
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified
The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …
Boehringer’s lung cancer drug Vargatef sees EU approval
November 28, 2014Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef
Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …
New Teva chairman announced
November 28, 2014Manufacturing and Production, Sales and Marketing Phillip Frost, Teva, Yitzhak Peterburg, barer, generics, israel
Teva Pharmaceutical Industries has confirmed that Professor Yitzhak Peterburg is to serve as its new chairman from January. Peterburg who …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
